[
  {
    "cui": "C0018378",
    "cui_name": "Guillain-Barre Syndrome",
    "incidence_per_100k": 1.7,
    "prevalence_per_100k": null,
    "metric_type": "incidence",
    "total_cases_per_year": 136000,
    "confidence": 0.78,
    "is_subtype": false,
    "parent_disease": null,
    "reasoning": "GBS is an acute autoimmune neurological disorder with well-documented incidence around 1-2 per 100k person-years globally. Incidence metric appropriate for acute condition. Estimated 1.7 per 100k based on population-based epidemiological studies and surveillance data.",
    "data_quality": "strong",
    "geographic_variation": "moderate",
    "year_specific": false,
    "data_year": 2005,
    "source": "Rees JH et al. (1998). The epidemiology of Guillain-Barre syndrome in the UK. J Neurol Neurosurg Psychiatry. 64(1):59-64",
    "source_url": "https://pubmed.ncbi.nlm.nih.gov/9436730/",
    "source_type": "literature"
  }
]
